Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ticagrelor versus clopidogrel for aortic stiffness after angioplasty in peripheral artery disease
IRCT20241231064227N1Phase 3Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in arteriosclerosis obliterans comparing Clopidogrel + aspirin with Ticagrelor + aspirin (2 arms). Primary endpoint: Aortic stiffness. Started Jun 2025; status: completed.
02
Drugs
ticagrelorclopidogrelaspirin
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on IRCT20241231064227N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241231064227N1.